Namik Kemal University clinical trial pipeline

6 trials changed in the last 30 days: 1 stopped, 3 with notable changes, 2 with minor changes only.

1. Stopped

   Sternocleidomastoid Thickness in Sarcopenia

   Trial status changed: Not Yet Recruiting → Terminated

   Also in this update: Primary completion date changed from estimate of Feb 1, 2026 to Sep 1, 2026; Final enrollment: 20 participants (planned 80)

   Namik Kemal University·Not specified· NCT05928845· Registry history of NCT05928845 on ClinicalTrials.gov (opens the registry)

   Sep 29, 2026

2. Notable

   TMS Treatment on Defense Mechanisms and Functionality · Depression

   Phase changed: not applicable → not specified

   Also in this update: Primary endpoint(s) modified; Interventions modified

   Namik Kemal University·Not specified· NCT07853989· Registry history of NCT07853989 on ClinicalTrials.gov (opens the registry)

   Oct 13, 2026

3. Notable

   EOIPB-ON · Modified External Oblique Intercostal Plane Block…EOIPB-ON · Modified External Oblique Intercostal Plane Block Versus Erector Spinae Plane Block for Open Nephrectomy

   Recruitment opened

   Namik Kemal University·Not applicable· NCT07726550· Registry history of NCT07726550 on ClinicalTrials.gov (opens the registry)

   Sep 25, 2026

4. Notable

   Epidural Analgesia With Intra-Articular Infiltration Analgesia

   Primary completion date changed from estimate of Sep 28, 2025 to Apr 15, 2026

   Also in this update: Completed without a posted recruiting period

   Namik Kemal University·Not applicable· NCT06872528· Registry history of NCT06872528 on ClinicalTrials.gov (opens the registry)

   Oct 23, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.